The Value of UV-C Robots to Enhance Infection Prevention/Control and Environmental Services Functions in Healthcare Facilities>>>

By INDEX Editorial Team | Based on peer-reviewed research –

UV-C robots add a repeatable disinfection step after routine cleaning and disinfection—but their value depends on safe deployment, sound workflows, and realistic expectations.

Hub: Healthy Indoor Productivity
Audience: Healthcare facility managers, infection prevention teams, and environmental services (EVS) leaders

INDEX approaches this topic through its 501(c)(3) nonprofit mission and Science-to-Solution methodology: consider the research, identify the practical problem, and assess potential solutions against clear criteria. This article is educational, not a product endorsement or substitute for facility policy, infection prevention guidance, or manufacturer instructions.

Why healthcare facilities are considering UV-C robots

Environmental services teams work within a demanding balance: rooms must be cleaned consistently, patients and staff need safe spaces, and care areas must return to use without unnecessary delay. Even a well-designed cleaning and disinfection program can face practical challenges, including tight room-turnover windows, complex equipment layouts, staffing pressures, and the need to verify that established procedures are followed.

UV-C robots are one technology facilities may consider as part of a terminal-disinfection process. They emit ultraviolet C light, typically from a mobile device positioned in an unoccupied room. The light can inactivate microorganisms on surfaces it reaches, without leaving a chemical residue. But a robot cannot remove soil, disinfect a surface hidden in shadow, or take the place of the trained people who carry out cleaning and disinfection.

The central question, then, is not whether a UV-C robot is “worth it” in the abstract. It is whether a particular device can address a defined facility need, fit into the existing EVS and infection prevention workflow, and deliver measurable process benefits at a justified cost.

What UV-C robots do—and what they do not do

UV-C is a band of ultraviolet light used for germicidal applications. When a sufficient dose reaches a microorganism, it damages genetic material and limit the organism’s ability to replicate. A UV-C robot is designed to bring a light source into a room and deliver exposure according to a device-specific cycle, sometimes using programmed routes or sensors.

The most important limitation is line of sight. UV-C does not reliably disinfect surfaces that are blocked from the light source. Beds, carts, equipment, door recesses, and other objects can create shadowed areas. Dose also depends on factors such as distance, exposure time, angle, lamp output, room geometry, and the target organism. Different organisms may not respond equally to a given exposure.

That is why a UV-C cycle should be considered an additional step—not a stand-alone hygienic method. Cleaning removes visible soil and organic matter.  UV-C cannot perform that task. CDC cleaning guidance emphasizes systematic procedures, clear responsibility for surfaces and equipment, and risk-based decisions about cleaning frequency and method. [1]

Criteria first: 8 questions to ask before considering a UV-C robot

A technology purchase should begin with a defined operational or infection-prevention need, not a device demonstration. These criteria can help a facility assess whether a UV-C robot is a practical option for consideration.

1. What specific problem are you trying to solve?

Identify the unit, room type, workflow step, or performance gap the technology is intended to address. For example: Is the facility seeking more consistent terminal disinfection in selected rooms? Is it responding to environmental monitoring findings? Is the goal process traceability, or a reduction in a particular infection outcome? These are different objectives and require different measures of success.

2. Does the device document exposure and cycle completion?

Ask what the system records: room or cycle identification, cycle duration, device position, delivered dose estimates, interruptions, and operator actions. Clarify what is measured directly and what is inferred from programmed settings. A completed cycle log is evidence that a device ran; it does not, by itself, prove that every relevant surface received an effective dose.

3. Can it address the room’s real layout?

Review how the system accounts for room size, surface orientation, equipment placement, and shadowing. Ask whether the workflow requires multiple device positions, manual repositioning, or clearing and moving equipment. A route that works in a demonstration room may not work in a fully equipped patient room or a busy intensive care environment.

4. Are safety controls suitable for the intended setting?

UV-C exposure can harm eyes and skin. Facilities need clear controls to prevent people from being exposed during operation, including access restrictions, warning indicators, door or motion sensors where provided, emergency stops, and a documented response to interruptions. Verify device safety information, training needs, and the facility’s own risk assessment. Do not assume that “autonomous” means the unit can safely operate without oversight.

5. Does the process integrate with EVS and clinical responsibilities?

Determine who prepares the room, removes obstacles, operates or supervises the device, confirms completion, and releases the room for use. Clarify how the robot interacts with environmental services, nursing, infection prevention, and room-flow teams. A poorly defined handoff can create delays or uncertainty about whether proper hygienic measures were completed.

6. Is the equipment compatible with the care environment?

Review manufacturer guidance for materials and equipment in the room, including plastics, fabrics, sensors, displays, and other surfaces exposed to repeated cycles. Ask about maintenance schedules, lamp or component replacement, calibration, service response, and staff training. Assess whether device size, navigation, and charging arrangements work in the intended area.

7. Can the facility measure outcomes that match its goal?

Separate process measures—such as cycle completion, time added to or subtracted from room turnover, or protocol adherence—from environmental measures, such as surface sampling results, and from clinical outcomes, such as infection rates. A change in one measure does not automatically demonstrate a change in another. Infection rates are influenced by many factors beyond room-surface disinfection.

8. Does the expected value justify the full cost?

Estimate more than the purchase price. Include training, maintenance, servicing, room downtime, staffing, workflow changes, and any required supplies or infrastructure. Compare those costs with a plausible, measurable benefit for the specific use case. Do not rely on a general promise of savings or avoided infections without facility-specific assumptions and supporting data.

What the research says: promising surface results, more uncertainty about patient outcomes

Peer-reviewed studies show why UV-C robots attract interest—and why claims about their value should be carefully qualified.

A 2023 study in a 1,158-bed teaching hospital examined a UV-C robot used after standard cleaning and disinfection in critical areas. Researchers sampled high-touch surfaces before cleaning, after the hospital’s standard cleaning and disinfection procedure, and after UV-C exposure. After standard cleaning and disinfection, 103 of 160 samples were positive for microbial cultures; after the additional UV-C treatment, 28 of 160 were positive. The study also found that some samples had higher microbial counts after standard cleaning and disinfection, prompting an audit that identified process issues involving reusable cloths and chemical handling. [2]

These findings suggest two practical points. First, UV-C can add a measurable, beneficial environmental step in a studied workflow. Second, technology should not distract from improving the fundamentals. The study’s cleaning audit revealed opportunities to address standard operating practices alongside the use of the robot. Surface results from one hospital and protocol are not a guarantee that another facility will see the same effect.

A 2023 systematic review and meta-analysis examined UV-C disinfection systems and infection outcomes across nine studies, all conducted in the United States. The pooled analysis found no statistically significant reduction in Clostridioides difficile or vancomycin-resistant enterococcal infection rates. It reported a possible reduction in Gram-negative rod infections, but that finding came from a small number of studies. The authors noted variation in study designs and limitations that affect how confidently results can be generalized. [3]

The distinction matters for healthcare leaders: a device may reduce microbial contamination on sampled surfaces without proving that it reduces infections in patients. Assessment of the device’s ability to reduce airborne microbial exposures is also important. Clinical outcomes are affected by many interacting factors, including hand hygiene, patient risk, clinical practice, organism transmission routes, standard cleaning and disinfection quality, and the frequency and timing of device use. A facility should avoid treating laboratory or surface-sampling results as equivalent to demonstrated reductions in healthcare-associated infections.

Where a UV-C robot may fit in EVS operations

If a facility identifies a suitable need, a UV-C robot may be evaluated as a supplement to terminal disinfection in selected rooms or care areas. The best-fit application depends on the room’s use, occupancy, layout, existing cleaning and disinfection process, and the facility’s safety protocols.

A practical sequence may look like this:

• EVS staff complete the facility’s standard cleaning and disinfection procedure.
• The responsible staff member checks that the room is unoccupied and prepared for the UV-C cycle.
• A trained operator positions or starts the device according to the approved protocol.
• The team verifies cycle status and records any interruption or exception.
• The room is released according to local policy and the device’s instructions.

This sequence should not be assumed to fit every facility. Some rooms may be continuously occupied, too cluttered, or too operationally busy for a safe and reliable cycle. In a 2023 robot study, the authors described practical challenges in active clinical environments, including the need for room evacuation and human oversight. [2]

Facilities should also clarify boundaries between EVS responsibilities and clinical equipment reprocessing. A whole-room UV-C cycle does not replace cleaning or reprocessing requirements for patient-care devices, and it should not be used to resolve uncertainty about who owns a surface or task. Written procedures, checklists, and training remain essential.

How to run a responsible pilot

A limited pilot can help a facility understand whether the technology works in its own setting before making a broader commitment. Start with a defined location, a specific use case, and an agreed baseline. Involve EVS, infection prevention, facilities, nursing, procurement, and staff who will operate or work around the device.

Before the pilot, document the current cleaning workflow and decide which indicators matter. These might include cycle completion, room-turnover time, interruption frequency, staff training requirements, device uptime, and environmental sampling results where appropriate. If the facility is interested in patient infection outcomes, plan in advance how those outcomes will be interpreted and what other changes could influence them.

During the pilot, track both intended benefits and added burdens. If the cycle regularly delays room availability, requires repeated manual intervention, or cannot reach important surfaces in the actual room configuration, those are relevant findings. Equally, a pilot should capture whether the device’s logs and safety controls support reliable use—not just whether the device can complete a demonstration cycle.

At the end, compare results with the baseline and the facility’s stated objectives. A decision to continue should rest on evidence of local workflow fit and useful, verifiable performance—not on broad claims that a robot will automatically improve infection outcomes or effectively complement EVS labor.

The bottom line

UV-C robots offer healthcare facilities a repeatable, no-touch disinfection step for selected unoccupied rooms after standard cleaning and disinfection. Research has reported reductions in microbial contamination on surfaces in some settings, but the evidence connecting UV-C implementation to lower infection rates is mixed and limited. The technology’s performance also depends on exposure, room layout, shadowing, safe operation, and reliable integration with human-led cleaning and disinfection practices.

For facility leaders, the most useful question is not “Should every hospital have a UV-C robot?” It is: “Is there a defined need in our facility that this technology can address, and can we measure whether it does so safely and at a reasonable operational cost?” That criteria-first approach supports informed decisions without overstating what the current evidence can establish.

Support the Research Behind This Article

Support our work.

Donate →

Author attribution: By the INDEX Editorial Team | Based on peer-reviewed research. INDEX is a 501(c)(3) environmental health nonprofit. Our Science-to-Solution methodology connects research with practical pathways for healthier indoor environments.